America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...

CVS Health stock sold for $72.08 a share when Karen Lynch became president and CEO in 2021. It closed at $60.35 on Friday.

Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in ...

CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company ...

The pharma chain giant recently engaged strategic advisors about possibly breaking off its insurance and retail business.

Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state ...

After Friday morning’s announcement that CVS CEO Karen Lynch was being forced out of the top spot and that she was being ...

CVS Health Corp. named David Joyner as its new chief executive officer, ending a tumultuous tenure for Karen Lynch at the ...

On the heels of its recent announcement that CVS Health will eliminate about 2,900 jobs nationwide, the health care giant is ...

The company said third-quarter results will fall well below expectations, largely due to continued issues at its Aetna ...

The move comes after the company repeatedly missed earnings targets, spurring activist interest and setting off unrest among ...